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Abstract
Background: Beside their health benefits, dietary omega 3 polyunsaturated fatty acids (n-3 PUFA) might impair host
resistance to Mycobacterium tuberculosis (Mtb) by creating an immunosuppressive environment. We hypothesized that
incorporation of n-3 PUFA suppresses activation of macrophage antimycobacterial responses and favors bacterial growth, in
part, by modulating the IFNc-mediated signaling pathway.
Methodology/Principal Findings: Murine macrophage-like J774A.1 cells were incubated with bovine serum albumin (BSA)-
conjugated docosahexaenoic acid (DHA; 22:6n-3) or BSA alone, activated with recombinant IFNc, and infected with a
virulent strain (H37Rv) of M. tuberculosis. The fatty acid composition of macrophage membranes was modified significantly
by DHA treatment. DHA-treated macrophages were less effective in controlling intracellular mycobacteria and showed
impaired oxidative metabolism and reduced phagolysosome maturation. Incorporation of DHA resulted in defective
macrophage activation, as characterized by reduced production of pro-inflammatory cytokines (TNFa, IL-6 and MCP-1), and
lower expression of co-stimulatory molecules (CD40 and CD86). DHA treatment impaired STAT1 phosphorylation and
colocalization of the IFNc receptor with lipid rafts, without affecting surface expression of IFNc receptor.
Conclusions/Significance: We conclude that DHA reduces the ability of J774A.1 cells to control M. tuberculosis in response
to activation by IFNc, by modulation of IFNc receptor signaling and function, suggesting that n-3 PUFA-enriched diets may
have a detrimental effect on host immunity to tuberculosis.
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Introduction
Tuberculosis (TB), a bacterial disease caused by Mycobacterium
tuberculosis (Mtb), continues as a public health problem [1]. Host
resistance to this pathogen requires the development of an effective
cellular immune response, mediated mainly by T cells and
macrophages [1]. The activation of these cells can be modulated
by nutritional components, such as carbohydrates, proteins and
vitamins, impacting subsequently on the resistance to TB [2,3,4].
On the other hand, lipids can regulate the host response against
Mtb. Fatty acids such as arachidonic acid increase bacterial killing
in macrophages [5]; while cholesterol impairs immunity against
Mtb [3]. Moreover, it was recently reported that eicosapentaenoic
acid (EPA), an n-3 polyunsaturated fatty acid (n-3 PUFA),
increased mycobacterial growth by reducing TNFa secretion in
macrophages [6]. However, the role of distinct classes of long
chain dietary fatty acids during TB infection has not been well
investigated to date.
Dietary n-3 PUFA are found in cold water fish and fish oils and
their effect on immune responses has been studied extensively.
The anti-inflammatory properties of n-3 PUFA make them useful
as a therapy for chronic inflammatory diseases, autoimmune
disorders and cancer [7,8,9]. However, epidemiological studies
have linked n-3 PUFA-enriched diets not only with a reduced
incidence of inflammatory diseases but also with an increased
incidence of TB [10]. We previously aerosol challenged transgenic
fat-1 mice, which endogenously produce n-3 PUFA, and fish oil-
fed guinea pigs with H37Rv Mtb and bacteriological and
histological analysis revealed that n-3 enrichment enhances
susceptibility to TB infection, as demonstrated by higher bacterial
loads and less robust inflammatory responses in lungs [11],[12].
Macrophages are both host cells for Mtb and effector cells for
host resistance, being responsible for mycobacterial killing. The
effectiveness of the macrophage antimycobacterial activity
depends on an appropriate level of cell activation [13],[14].
IFNc activates macrophage maturation [15], inducing upregu-
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lation of proinflammatory cytokines and surface markers.
However, n-3 PUFA have been found to impair IFNc-induced
activation [16] thereby reducing the ability to kill some
pathogens [17] and to stimulate an acquired immune response
[18]. Different processes important for killing activity are
affected by DHA, including the respiratory burst [19],
chemotaxis [20], antigen presentation [21], the expression of
adhesion molecules [18] and major histocompatibility complex
(MHC) [18],[22]. DHA-treated cells also produce less proin-
flammatory eicosanoids [23] and cytokines [24] which are
important for a protective response against TB [25,26].
Furthermore, lipids can influence phagolysosome maturation
[5] and endosomal membrane lipid composition [27], which is
critical for mycobacterial clearance
We demonstrate that IFNc-treated macrophages cultured in
vitro with DHA are more permissive to Mtb infection in
association with several measurements of defective cell activa-
tion. The reduced capacity of DHA-treated, IFNc-activated
macrophages to control the infection was accompanied by
defects on proinflammatory cytokine production, phagolyso-
some maturation, and oxidative burst. Furthermore, DHA
significantly affected the early events of cell signaling in IFNc-
treated macrophages which may explain, in part, the negative
effects of DHA on macrophage resistance to Mtb.
Results
DHA treatment alters lipid membrane composition
J774A.1 cells efficiently incorporate fatty acids provided in the
culture medium into their cell membranes under the conditions
used in this study. Table 1 shows that DHA-treated cells
significantly (p,0.05) increased the DHA content into their
membrane phospholipids. The amount of DHA (22:6n-3) in
DHA-treated cells was 18.260.5 mol%, compared to
2.1560.50% in cells incubated with medium alone (Control).
We and others have reported similar levels of DHA, exceeding
10%, on both total and phospholipid fractions in peritoneal
macrophages and splenic T-cells from mice fed diets enriched with
DHA [28,29,30,31].
DHA treatment impairs macrophage activation
In order to examine the effect of DHA incorporation on
activation of infected J774A.1 cells, we measured the production of
proinflammatory cytokines and expression of costimulatory
molecules. IFNc-induced activation of infected cells was impaired
significantly by DHA. As seen in Figure 1, there was significant
upregulation of TNFa between 24 h and 48 h and IL-6 at 24 h in
infected cells. DHA significantly reduced TNFa protein levels at 3,
24 and 48 h in infected IFNc-stimulated cells (Fig. 1A). For
example at 24 h, DHA treatment resulted in a 37% reduction in
TNFa production, compared to control. In panel B, DHA
significantly reduced IL-6 levels at 6, 24 and 48 h (Fig. 1B). The
percentage of DHA-induced reduction was 74% at 48h (p,0.01).
We observed a similar suppressive effect of DHA after LPS
treatment and on MCP-1 levels (Data not shown). The production
of IL-12p70, IL-10 and IFNc was not affected by DHA under our
experimental conditions.
DHA significantly suppressed upregulation of CD40 and CD86
in infected cells primed with IFNc. For example, Figure 2 shows
significant (p,0.05) differences in the CD86 percentage of PE
fluorescence between DHA (69.364.5%) and control
(84.664.6%), as well as 35% reduction in CD40 expression. No
significant changes in CD14 expression were observed (data not
shown). The observed differences in cytokine production and
surface molecule expression were not explained by changes in cell
viability, proliferation or adherence (data not shown). We
confirmed that these effects were specific for DHA by comparing
the same responses in cells treated with two control fatty acids, AA
and PA. J774A.1 cells treated with AA or PA did not exhibit
significant changes in TNFa production or CD40/CD86
expression (Figure S1a). As shown in Figure S1b, significant
(p,0.05) differences in the CD86 percentage of PE fluorescence
between DHA (69.364.5%) and other treatments (Control
84.664.6%, AA 89.662.3, PA 84.364.2).
DHA reduces macrophage ability to control M.
tuberculosis infection
In order to determine if DHA incorporation impaired the ability
of IFNc-treated J774 cells to control Mtb, we measured
intracellular bacterial accumulation by flow cytometry and
bacterial survival by the colony forming unit (CFU) assay.
Figure 3A shows that the percentage of infected cells increased
with time in all treatment groups. DHA-treated cells were more
permissive to the infection as 31.661.4% of the cells were infected
after 60 min, using MOI of 10; reaching 42.361.6% of infection
over 90 min whereas infection in the control group only reached
22.460.9% and 33.260.4%, respectively (p,0.01). The differen-
tial bacterial accumulation was confirmed by fluorescence
microscopy (Data not shown). Moreover, DHA facilitated
bacterial persistence within macrophages. As shown in panel B,
a greater number of viable mycobacteria were recovered from
DHA-treated cells at all intervals (30 min, 1 h, 1, 3 and 7 d),
although statistical significance was only achieved at 1 h, 1, and
3 d (p,0.05). J774A.1 cells treated with AA or PA did not exhibit
significant changes in bacterial growth (Figure S2a).
Table 1. Fatty acid composition in phospholipid fractions
from fatty acid-treated J774A.1 cells.
Treatments
Fatty Acid Control DHA
14:0 (myristic acid) 3.5560.15 3.7660.13
14:1 (myristoleic acid) 2.1660.37 2.0960.26
16:0 (palmitic acid) 27.1160.43 31.046.032
16:1n-7 (palmitoleic acid) 8.9160.23 6.4060.01
18:0 (stearic acid) 10.4460.28 9.4660.20
18:1n-9 (oleic acid) 20.9360.32 13.3660.15
18:1n-7 (vaccenic acid) 10.1560.32 6.9160.10
18:2n-6 (linoleic acid) 5.5660.79 2.6960.06
20:4n-6 arachidonic acid) 5.7460.59 5.0160.06
22:4n-6 (adrenic acid) 060 060
22:5n-6 (docosapentaenoic acid) 0.8460.02 060
22:5n-3 (docosapentaenoic acid) 1.4960.39 1.0760.00
22:6n-3 (docosahexaenoic acid-DHA) 2.1560.50 18.2460.52*
Cells were incubated with 50uM DHA for 24 hours and the lipid incorporation
was assessed by gas chromatography, as described in the Materials and
Methods. Results are expressed as mol per 100 mol of total fatty acids and only
selected major fatty acids (.1mol%) are reported. Values represent mean 6 SE
(n = 3).
*Significantly different from Control (Cells treated with no fatty acids) in the
same fraction, p,0.05. Abbreviations used: DHA, docosahexaenoic acid.
doi:10.1371/journal.pone.0010878.t001
Omega3 and Mycobacteria
PLoS ONE | www.plosone.org 2 May 2010 | Volume 5 | Issue 5 | e10878
DHA impairs phagolysosome maturation
Since DHA impaired bacterial control in IFNc-treated cells, we
focused on cell processes which are enhanced by IFNc and
fundamental to the control of intracellular mycobacteria. The
fusion of Mtb-containing phagosomes with compartments of the
endocytic pathway plays an important role in antimycobacterial
activity by releasing the lysosome content into the mycobacterial
compartment. In order to determine the effect of DHA on
phagosomal maturation, we assessed the incorporation of the
acidotropic probe lysotracker into mycobacterial phagosomes.
IFNc treatment resulted in increased colocalization of Mtb and
lysotracker (MOI 20) (Control 11.362.5% vs IFNc 58.463.8%).
We observed reduced lysotracker colocalization in IFNc-primed
cells treated with DHA (Fig 4A), showing that the activating effect
of IFNc was significantly reduced by DHA. DHA induced a
62.22% reduction in lysotracker-positive mycobacterial phago-
somes over 1 h after infection (Fig. 4C; DHA 13.660.8% vs
Control 36.061.3%, p,0.01). Additionally, we examined matu-
ration of phagosomes by monitoring acquisition of early (Rab5)
and late endosomal markers (LAMP1, LAMP-3 and Rab7).
Figure 4B shows representative fluorescent images of the reduced
recruitment of LAMP1, LAMP-3, Rab-5, and Rab-7 to myco-
bacterial phagosomes in DHA-treated cells. Panel C summarizes
the percentage of Mtb-containing phagosomes colocalizing with
lysosomal markers. We observed significantly reduced phagolyso-
some maturation in infected IFNc-primed cells treated with DHA.
DHA treatment resulted in significantly decreased presence of
Lamp-1 (DHA 29.761.0% Vs Control 44.261.1%; p,0.05),
Lamp-3 (DHA 20.861.6% Vs Control 35.662.4%) and Rab7
(DHA 29.161.6% Vs Control 49.061.1%; p,0.01) in mycobac-
terial phagosomes. We confirmed that DHA-induced alterations in
mycobacterial infection and phagolysosomal maturation were
specific for an n-3 PUFA. As show, in Figure S2b, no significant
changes in either of these parameters were observed in J774A.1
cells treated with AA or PA.
DHA suppresses the respiratory burst
The generation of reactive intermediates derived from oxygen
or nitrogen is necessary for resistance to TB. In order to determine
the effect of DHA on oxidative metabolism, we assessed the ability
of DHA-treated macrophages to generate ROS following
infection. In the presence of DHA, IFNc-treated Mtb-infected
J774A.1 cells exhibited significantly (p,0.01) reduced oxidative
activity (MOI 10). Figure 5 shows that cells treated with DHA
exhibited a significantly decreased percentage of EB fluorescence
(DHA 24.463.7% vs Control 51.264.2%; p,0.01). The dye
used, dyhydroethidium (DHE), is oxidized by ROS to ethidium
bromide (EB), which emits red fluorescence. Background oxida-
tion of DHE occurred due to macrophage metabolic activity
(uninfected cells 11.464.7). The suppressive effect was also seen
following LPS treatment (Data not shown). Overall, these data
Figure 1. Suppression of TNFa and IL-6 by DHA in infected J774A.1 cells after IFNc treatment. Macrophages were incubated with 50uM
DHA for 24 h and infected with M. tuberculosis for 1 h. Culture supernatants were quantified for TNFa and IL-6, as described in the Materials and
Methods. Cells were originally seeded at a density of 250,000 cells/well. a. Quantitative data represent the concentration of TNFa and b. IL-6 post
infection (pictograms per milliliter; mean6 SEM; n = 9).* Indicates a significant effect of DHA within the same interval compared to Control, * p,0.05
** p,0.01. c. Representative histogram of the reduced IL-6 levels (lower intensity of fluorescence) in DHA-treated cells, compared to Control at 6 h
post infection. The analysis was restricted to the fluorescent beads coated with antibodies to IL-6. Data are representative of three independent
experiments. Abbreviations used: DHA, docosahexaenoic acid.
doi:10.1371/journal.pone.0010878.g001
Figure 2. DHA reduces expression of CD40 and CD86 in
infected J774A.1 cells primed with IFNc. Macrophages were
incubated with 50uM DHA for 24 hours and infected with M.
tuberculosis for 1 h. Then cells were incubated with PE-conjugated
antibodies to CD40 and CD86 and intensity of fluorescence was
quantified by flow cytometry, as described in the Materials and
Methods. Cells were seeded at a density of 500,000 cells/well. a.
Quantitative data represent the relative percentage of PE fluorescence
(mean 6SEM; n = 9) for CD40 and CD86. * Indicates a significant effect
of DHA compared to Control, * p,0.05. b. Comparative histograms of
CD40 and CD86 expression in fatty acid-treated cells in DHA-treated
cells after 24 h, compared to other fatty acid treatments. Data are
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suggest that the increased bacterial loads found in DHA-treated
cells might be explained by an impaired oxidative burst. We
confirmed that these effects were specific for DHA by comparing
the same readouts in J774A.1 cells treated with AA or PA. As
shown in Figure S3, the only significant treatment effect was
observed with DHA treatment.
DHA downregulates cell signaling
To better understand the underlying mechanisms by which DHA
negatively affects IFNc-mediated macrophage activation, non-
infected J774.1 cells treated with DHA and activated with IFNc
were fluorescently stained with antibodies to IFNcR1 and IFNcR2.
As shown in Figure 6a, DHA treatment alone did not affect the cell
Figure 3. DHA reduces mycobacterial killing in IFNc-stimulated J774A.1 macrophages. Cells were incubated with 50uM DHA for 24 h and
infected with10 MOI GFP-expressing M. tuberculosis for 1 h. a. The relative percentage of Mtb-infected cells was quantified by flow cytometry, as
described in the Materials and Methods. Quantitative data represent the percentage of infected cells (mean 6SEM; n = 9). DHA increases bacterial
survival in infected J774A.1 cells. b. Bacterial counts were estimated at different time points by the CFU assay, as described in the Materials and
Methods. Data show bacterial survival as Log10 CFU (mean6 SEM; n= 10). Cells were seeded at a density of 250,000 cells/well. * Indicates a significant
effect of DHA compared to other treatments, * p,0.05, **p,0.01. Abbreviations used: DHA, docosahexaenoic acid.
doi:10.1371/journal.pone.0010878.g003
Figure 4. DHA reduces mycobacterial phagolysosome maturation in IFNc-primed J774A.1 cells. Cells were incubated with 50uM DHA for
24 h and infected with20 MOI GFP-expressing M. tuberculosis for 1 h. Cells were seeded at a density of 500,000 cells/well. Phagolysosome maturation
was defined based on acquisition of lysotracker by GFP-Mtb-containing phagosomes and visualized by fluorescent microscopy, as described in the
Materials and Methods. a–b. Representative images of the reduced colocalization induced by DHA, compared to Control. Data representative of three
independent experiments. c. Percentages of Lysotracker-, LAMP-1, LAMP3-, Rab5-, Rab7-positive mycobacterial phagosomes. Data represent the
percentage of colocalization (mean6SEM; n = 5). * Indicates a significant effect of DHA compared to mock control, *p,0.05, **p,0.01. Abbreviations
used: DHA, docosahexaenoic acid; LAMP-1, lysosomal-associated membrane protein.
doi:10.1371/journal.pone.0010878.g004
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surface expression levels of IFNcR1 or IFNcR2 as assessed by mean
fluorescent intensity. Subsequent activation with IFNc slightly
enhanced the surface expression of IFNcR1, but not IFNcR2,
although this was not statistically significant. Therefore, the decrease
in cytokine expression (Fig. 1) and increase in bacterial loads (Fig. 3)
in DHA-treated, IFNc-activated cells cannot be explained by the
change in IFNc receptor expression levels.
To determine whether IFNc-induced cell signaling was affected
by DHA treatment, non-infected cells were treated with DHA and
activated with IFNc at various time points. The lysates were
immunoblotted with specific antibodies to total and phospho-
STAT1 to determine the activation status of these cells. Figure 6b
shows a representative image of the phospho- and total STAT1
content in J774.1 cells at intervals up to 60 min following IFNc
activation. DHA treatment had no affect on total STAT1 protein
expression, and the expression of phosphorylated STAT1 peaked
at 60 min post-activation in both DHA-treated and untreated
cells. However, quantitative densitometry analysis (Fig 6c)
indicated that DHA treatment significantly suppressed the
phosphorylation status of STAT1 protein at both 30 min and
1 h post-activation with IFNc. These data imply that DHA may
impair downstream cell signaling events of the IFNc receptor and,
thus, suppress cell function.
DHA interrupts colocalization of lipid rafts and IFNc
receptor
The observation that DHA treatment did not affect total IFNcR
expression, but did impair downstream signaling via STAT1,
suggested that IFNcR function might be altered by DHA. To
determine whether DHA affected recruitment of the IFNcR to
lipid rafts during cell activation, DHA-treated, non-infected
macrophages were activated with IFNc for 0, 5, 10, and 15 min
and fluorescently stained with anti-IFNcR1 antibody and anti-
GM1, a lipid raft marker. Confocal analysis showed that the
association of the IFNc receptor with the lipid raft marker peaked
at 5 min post-activation and steadily declined thereafter, demon-
strating the rapid occurrence of these events at the cell membrane.
The presence of DHA dramatically interrupted the interaction
between IFNc receptor and the lipid raft marker by ,80% at
5 min post-activation (Fig. 7). At all other time intervals,
colocalization events were similar in both the DHA and control
group. Taken together, these data demonstrate that while DHA
does not directly affect the surface expression levels of the IFNc
receptor, it does impair cell activation by disrupting the
localization of the receptor to lipid rafts and thus, phosphorylation
of key signaling molecules critical for cell function.
Figure 5. DHA impairs oxidative metabolism in infected
J774A.1 cells under IFNc treatment. Cells were incubated with
50uM DHA for 24 h and infected with 20 MOI of Mtb. Reactive oxygen
intermediates were estimated by FACS, as described in the Materials
and Methods. a. Quantitative data show the relative percentage of EB
red fluorescence (mean 6 SEM; n = 9). * Indicates a significant effect of
DHA compared to Control, **p,0.01. Abbreviations used: DHA,
docosahexaenoic acid; EB, ethydium bromide.
doi:10.1371/journal.pone.0010878.g005
Figure 6. DHA does not affect the expression of IFNcR1 & R2 but decreases STAT1 phosphorylation in non-infected J774A.1 cells
primed with IFNc. Macrophages were incubated with 50uM DHA for 24 hours and then stimulated with or without IFNc (100 U/ml) for 24 h. The
cells were then labeled with PE-conjugated antibodies to IFNcR1 and IFNcR2 and intensity of fluorescence was quantified by flow cytometry, as
described in the Materials and Methods. Cells were seeded at a density of 500,000 cells/well. a. Quantitative data represent the Mean Fluorescence
Intensity (MFI) of PE fluorescence (mean6SEM; n = 9) for IFNcR1 and IFNcR2. No significant differences were found between DHA and control groups.
To measure STAT1 phosphorylation, cells were incubated with 50uM DHA for 24 hours and then stimulated with IFNc (100 U/ml) from 0–60 min. The
cells were then lysed in lysis buffer, loaded onto an SDS-PAGE gel, and transferred to a PVDF membrane as described in the Materials and Methods. b.
Representative immunoblots probed for anti-phospho STAT1 (p-STAT1) or total STAT1 proteins. c. Quantitative data of the relative expression of p-
STAT1 to total STAT1 (mean 6SEM; n= 6–9). Significant differences were found between control and DHA groups at 30 min and 1 h. Data are
representative of three independent experiments. Abbreviations used: DHA, docosahexaenoic acid.
doi:10.1371/journal.pone.0010878.g006
Omega3 and Mycobacteria
PLoS ONE | www.plosone.org 5 May 2010 | Volume 5 | Issue 5 | e10878
Discussion
Malnutrition [2], hypercholesterolemia [3], and diabetes [4] are
examples of host nutritional conditions associated with increased
susceptibility to TB. Although dietary n-3 PUFA are frequently
used as anti-inflammatory and tumor-suppressive treatments
[7,32], their immunosuppressive effects might negatively impact
the host defense against Mtb, in part, by interfering with activation
of macrophages. Our results support this conclusion. We
demonstrated that IFNc-activated macrophage-like J774A.1 cells
treated with DHA exhibited impairment in several indicators of
cell activation and increased susceptibility to virulent Mtb
infection. DHA treatment was associated with down-regulated
pro-inflammatory cytokine production, reduced antimicrobial
capacity, a weak oxidative response, diminished phagolysosome
maturation, and interrupted signaling events critical for IFNc-
induced cell activation. The immunosuppressive effect was unique
to DHA, per se, and not fatty acids in general. J774A.1 cells
treated with arachidonic acid (AA; 20:4 n-6) or palmitic acid (PA;
16:0) responded essentially the same as untreated cells and
significantly different from DHA-treated cells, as shown in
Supplemental Figures S1, S2, and 3. Therefore, the suppressive
effects on IFNc-induced macrophage activation reported here are
unique to DHA. This is in agreement with previous studies done
by our group in which other fatty acids were used as controls to
demonstrate a DHA-specific effect on T-cell activation [33,34].
Our data are consistent with previous reports in which dietary
n-3 PUFA compromised host resistance to intracellular infections.
Mice fed with n-3 PUFA exhibited increased susceptibility to
Listeria monocytogenes [17], Herpes simplex type I [35], Salmonella
typhymurium [16], Paracoccidioides brasiliensis [36] and reovirus [37].
In agreement with our findings, these studies also reported
reduced production of pro-inflammatory cytokines, low expression
of accessory molecules and defective cell activation following n-3
PUFA feeding. Indeed, an increased dietary intake of n-3 PUFA
impaired resistance to TB in guinea pigs [12,38,39] and mice [11]
infected with virulent Mtb.
Cytokines such as TNFa [40] are not only markers of
activation, but also are essential to induce an effective macrophage
killing activity and for the development of a protective response
against TB. Since TNFa production was impaired in our studies
(Fig. 1), it is reasonable to propose that the bacterial control could
be also affected by DHA through this mechanism. Similar changes
in TNFa levels were recently reported in Mtb-infected J774A.1
cells treated with another n-3 PUFA, eicosapentaenoic acid (EPA)
[6]. The levels of incorporated DHA achieved in our study are
similar to previous reports in both murine [30,31], guinea pig [12]
and human cells [41], which reported DHA levels exceeding 10
mol% in vivo following fish oil feeding. In addition, our
experimental conditions (BSA-complex system and 24 h incuba-
tion) have been shown to maximize fatty acid incorporation
[42,43] and the J774A.1 cell line is a well-established model for
studies of mycobacterial pathogenesis and immune response
[44,45], as well as lipid metabolism [5,43]. However, experiments
beyond the scope of the present study will be necessary to
determine the relevance of our findings in primary lung or alveolar
macrophages. The finding of an increased bacterial internalization
and permissiveness in DHA-treated macrophages is supported by
previous studies in which DHA increased phagocytic activity
[30,46]. This finding raises the question of which specific event
during bacterial internalization [47] is being modulated by DHA;
e.g. binding to the cell surface, membrane invagination,
phagosome formation, phagolysosomal fusion, etc [47]. Based on
our data, it is unclear which event or events are modulated and
further experiments are necessary. The CFU results (Fig. 3C) are
consistent with the loss of mycobacterial control in DHA-cultured
cells, reported by Anes et al [5]. Jordao et al. reported reduced
antimycobacterial activity in J774A.1 cells treated with the n-3
PUFA, EPA [6]. Although we used very different experimental
conditions, our results are complementary to those of Anes et al.
and add significantly to the understanding of the n-3 PUFA effects.
The distribution of acidotropic probes and the recruitment of
endosomal proteins to mycobacterial phagosomes during the
maturation process have been well described. Lysotracker is an
acidotropic probe which accumulates into acidic compartments.
Lamps are membrane glycoproteins that accumulate into
lysosomes and late endosomes [48] and Rabs are small GTP
binding proteins which play a role in regulating membrane fusion
events within endocytic compartments [49]. Lysotracker is
commonly used as an indicator of phagosome maturation and
acidification in IFNc-activated cells. Although its accumulation
overlays compartments positive for specific lysosomal markers
[15,49], the lysotracker lacks specificity and needs to be validated
by detecting lysosomal proteins. We confirmed that robust
markers of phagosomal maturation like Rab7, LAMP1 and
LAMP-3 were excluded from mycobacterial phagosomes in
DHA-treated cells, showing reduced fusion of Mtb-containing
phagosomes with late endosomal compartments. However, since
only one time interval was evaluated, we cannot rule out transient
or delayed recruitment of those markers under DHA treatment.
Diverse molecular mechanisms at different cellular levels might
explain the observed DHA effect [50]. n-3 PUFA have been
shown to promote apoptosis in T cells [29] and colonocytes [51]
and to reduce cell attachment and proliferation. It is important to
note that we found no significant differences in cell viability,
proliferation or adherence among treatment groups (Data not
shown). It has been shown that DHA can modulate membrane
fluidity, permeability, and the distribution and activation of
Figure 7. Colocalization of raft marker GM1 with IFNcR is
impaired in DHA-treated, non-infected J774A.1 cells primed
with IFNc. Macrophages were incubated with 50uM DHA for 24 hours
and then stimulated with IFNc (100 U/ml) for0–15 min on chambered
slides. The cells were then fixed, washed and immunostained with FITC-
CTx (GM1) and IFNgR1 antibodies as described in the Materials and
Methods. Images were then collected by confocal analysis at 6126
magnification. Colocalization of IFNcR1 with the raft marker was
quantified as percentage of colocalized area (both green and red) over
total raft area (green). Images were randomly captured from a minimum
of 10 images per slide, with a minimum of 4 cells per image. Data are
representative of three independent experiments. Significant differenc-
es were found between control and DHA groups at 5 min. Abbrevia-
tions used: DHA, docosahexaenoic acid.
doi:10.1371/journal.pone.0010878.g007
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transmembrane proteins, receptors and channels [52] and
different membrane-associated processes, [53],[54]. We have
found that DHA did not mediate any changes in IFNc receptor
surface expression (Fig. 6) in non-infected cells. Similar findings
were reported in the peritoneal macrophages and splenocytes of n-
3 PUFA-fed IFNc knockout mice [55]. DHA did, however,
downmodulate the IFNc-mediated STAT1 signaling pathway by
decreasing STAT1 phosphorylation (Fig. 7), a critical pathway
induced by IFNc receptor activation. Accordingly, n-3 PUFA
reduced STAT-1 phosphorylation in the peritoneal macrophages
of n-3 PUFA-fed IFNc knockout mice [56]. This may be
explained, in part, by the disrupted interaction between the IFNc
receptor and lipid rafts (Fig. 7). Upon cell activation, lipid rafts
compartmentalize critical signal transducing molecules to form the
immunological synapse. We have recently reported that dietary n-
3 PUFA modulate T-cell lipid rafts and suppress the localization
and activation of signaling proteins such as PKCh and PLCc1
[33,54]. These molecular mechanisms may also be involved in the
decreased STAT1 phosphorylation and subsequent downstream
activation events in DHA-treated macrophages and remain to be
elucidated.
Current interest in n-3 PUFA focuses on their protective properties
against a wide range of inflammatory and autoimmune diseases.
Indeed, the U.S. Food and Drug Administration (FDA) permits the
inclusion of information regarding omega-3 health benefits on labels
for foods supplemented with n-3 PUFA. Moreover, LovazaH, a drug
which contains DHA and EPA, has been approved for use in humans
to reduce very high triglycerides levels. However, our findings raise
questions regarding the safety of n-3 supplementation. An improved
understanding of the lipid effect on intracellular infections, including
TB, will allow a better assessment of the potential health risks of
excessive intake of n-3 PUFA in humans, leading to the establishment
of dietary guidelines in order to avoid detrimental effects. We
hypothesize that diets supplemented with n-3 PUFA increase host
susceptibility to TB infection in vivo. However, our in vitro findings
reflect just partially the complexity of the immune response in
multicelullar hosts and need to be validated using in vivo systems.
Further investigation will be required to establish the effect of n-3
PUFA on resistance to TB in relevant animal models and to
determine what impact, if any, n-3 PUFA supplementation has in
people at risk of infection.
Materials and Methods
Cells
The murine-macrophage-like cell line J774.A1 (ATCC TIB-67)
was maintained in RPMI (Invitrogen) supplemented with 10%
heat-inactivated fetal bovine serum (FBS) (Atlanta Biol.) and 1%
penicillin-streptomycin (Gibco), in 5% CO2 at 37uC. Cells were
seeded in plates or glass coverslips and allowed to adhere
overnight. Cell monolayers were incubated for 24 h with 50 uM
conjugated BSA-DHA (docosahexaenoic acid; 22:6n-3) [21,57],
BSA-AA (arachidonic acid; 20:4n-6), BSA-PA (palmitic acid; 16:0)
or BSA alone. Fatty acids (FA) were conjugated at a FA:BSA 3:1
mole ratio and resuspended in RPMI, to mimic physiological
conditions according to Arrington et al [21,42]. The fatty acid
concentration used mimics the levels reached in human cells
supplemented with DHA [21,41,57] and the 24 h incubation time
was selected to maximize the incorporation of fatty acids based on
previous reports [43]. The fatty acid-treated cells were then
incubated with or without IFNc (100U/ml Biosource) to induce
activation. AA, and n-6 PUFA, was included to control for a
general polyunsaturated fatty acid effect. PA, a saturated fatty
acid, was used to control for a general unsaturated fatty acid effect.
Fatty acid profiles
Total lipids were extracted from fatty acid-treated J774A.1 cells
by the method of Folch [58]. Phospholipids were separated by
TLC, using chloroform/methanol/acetic acid/water as solvents.
Transesterification of the isolated phospholipids was performed in
presence of 6% methanolic HCl. Fatty acid methyl esters were
analyzed by capillary gas chromatography as previously described
[4,59]. Peaks of resolved fatty acids were identified by comparison
with standards (Nu Chek Prep).
Infection
The virulent strain H37Rv of M. tuberculosis (ATCC 27294) was
cultured in Middlebrook 7H9 medium (Becton Dickinson) and
stocks were prepared and stored at 280uC before use, according
to Grover et al [60]. For infection, bacteria were thawed, vortexed,
sonicated and passed through a 28G needle fifteen times to disrupt
bacterial clumps, as previously described [61]. Macrophages were
infected at a multiplicity of infection (MOI) of 10 or 20, according
to the type of experiment. Before infection, non-incorporated fatty
acids were removed from the culture and infected cells were
maintained in RPMI (Gibco) supplemented with 2% heat-
inactivated FBS (Atlanta Biol). At specific time points after
infection, cell monolayers were washed with PBS (Gibco) and
incubated with 50 mg/ml gentamicin (Gibco) to kill extracellular
bacteria [62].
Cytokine production
Culture supernatants were harvested and assessed for IL-6, IL-
12p70, TNFa, MCP-1, IL-10 and IFNc by flow cytometry using
the Cytometric Bead Array CBA mouse inflammation kit (Becton
Dickinson) according to the manufacturer’s protocol. The cytokine
concentration was determined by using the CBA software based
on calibration curves and the four-parameter curve fit option.
Supernatants from unstimulated cells were used to establish basal
levels of cytokine expression.
Costimulatory molecule and IFNc receptor expression
Monolayers were scraped and cells were resuspended in PBS.
Cells were incubated with phycoerythrin (PE)-conjugated rat anti-
mouse antibodies to CD14, CD40, CD86 (Becton Dickinson) and
IFNcRa and IFNaRb (Santa Cruz Biotechnology). Cells were
pretreated with a rat anti-mouse CD16/CD32 to block non-
specific binding and a PE-conjugated rat IgG (Becton Dickinson)
with low background binding used as isotype control. Cells were
fixed in 2% paraformaldehyde in PBS and analyzed using a
FACSCalibur flow cytometer (Becton Dickinson). CellQuest
software was used to determine both intensity and percentage of
PE fluorescence.
Bacterial permissiveness
Cells were seeded in Petri dishes (Fisher) or on glass coverslips
(Corning) at a density of 56105 cells and left to form monolayers
overnight. Monolayers were infected with a green fluorescent
protein (GFP)-expressing virulent strain (H37Rv) of Mycobacterium
tuberculosis, kindly provided by Dr. Scott Franzblau (University of
Chicago) [63]. Nuclei were counterstained with 1 mM Hoescht
33342 (Fluka). Discrimination between intracellular and extracel-
lular bacteria was accomplished by using simultaneously a
polyclonal primary antibody E193.1.11.WCL against whole cell
lysate of Mtb, kindly provided by Dr Karen Dobos-Elder
(Colorado State University). Serial sections across entire cells were
taken with a Z-stack spanning a thickness of 15 um and a step size
of 0.5 um, and 3D reconstruction was performed to confirm the
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intracellular bacterial localization. The percentage of cells with
internalized bacteria was determined in an Olympus disk scanning
confocal microscope by using Slidebook software and by flow
cytometry using CellQuest software.
Mycobacterial survival
After infection, monolayers were lysed with 0.1% SDS (Sigma).
Lysates were serially diluted and plated on 7H10 Middlebrook
agar (Becton Dickinson). The colony forming unit (CFU) counts
were determined after 3–4 weeks of incubation at 37uC in 5%
CO2, as described previously [40]. Data are expressed as mean
log10 viable CFU.
Phagolysosome maturation
Cells were infected with GFP-expressing bacteria and incubated
with 50 nM Lysotracker Red DND99 (Invitrogen) for 2 h before
and during the infection. Alternatively, cells were fixed with 3.7%
formaldehyde, permeabilized with 0.2% Triton X-100 (Sigma)
and blocked with 2% BSA fraction V (Sigma) and 0.02% Tween-
20 in MgPBS before incubation with primary antibodies against
LAMP-1 (Sigma), Rab5, Rab7 and LAMP-3 (SantaCruz Biot), as
described by Vergne et al [14]. A secondary PE-conjugated
antibody (Becton Dickinson) was added and nuclei were
counterstained with 1 mM Hoescht 33342 (Fluka). Coverslips
were mounted onto slides using Slowfade Gold mounting medium
(Invitrogen) and analyzed on an Olympus disk scanning confocal
microscope by using Slidebook software. The quantitative scoring
of colocalization was done by determining the percentage of
lysosomal marker- positive mycobacterial phagosomes. For each
group, at least 100 Mtb-containing phagosomes were counted and
scored for the presence of lysosomal markers. Serial sections were
taken with Z-stack spanning to confirm colocalization.
Reactive oxygen species (ROS) production
Cells were infected and intracellular ROS levels were measured
by staining with oxidative fluorescent dyes 10 uM 5-(and 6-)-
chloromethyl-29,79-dichlorodihydrofluorescein diacetate acetyl es-
ter (DCFDA) (Invitrogen) and 5uM Dihydroethidium (DHE)
(Invitrogen), according to Carter et al [64]. DHE becomes a
fluorescent compound (Ethidium bromide, EB) after oxidation by
reactive species, including O22, H2O2 and NO. The intensity of
red EB fluorescence is proportional to ROS concentration. DHE
oxidation can occur due to basal macrophage metabolic activity
[65], therefore background was subtracted using uninfected cells
as control. Cells were fixed in 2% paraformaldehyde in PBS and
analyzed using a FACSCalibur flow cytometer (Becton Dickinson).
CellQuest software was used to determine both intensity and
percentage of EB fluorescence.
Western blot analysis
Monolayers of J774.1 macrophages treated with IFNc for
various intervals (0, 10, 15, 30 and 60 min) were resuspended in
RIPA lysis buffer (Santa Cruz Biotechnology) and cell lysates
stored at 280uC until further analysis. Cell lysates were
electrophoresed on a 4–12% Tris-Glycine gel (Invitrogen) and
transferred to a PVDF membrane for immunoblotting. The
membranes were incubated overnight in a 1:500 dilution of anti-
phospho-STAT1 or total STAT1 antibody (Millipore/Upstate)
followed by a 1 h incubation with goat anti-rabbit 2u antibody
conjugated to HRP (1:1000). Chemiluminescence substrate (Super
Signal West Femto; Pierce) was used to develop the reaction and
bands were captured on a BioRad Imager and quantified using
QuantityOne software (BioRad laboratories).
Colocalization experiments
J774.1 macrophages were seeded onto poly-L-lysine coated
cover glass slides as described previously [54]. After cells were
allowed to adhere for 30 min, they were treated with DHA and
IFNc as described previously. Cells were then fixed in 4%
paraformaldehyde for 20 min, rinsed with PBS, and incubated
with 10 nmol/L glycine in PBS for 10 min to quench aldehyde
groups. Cell membranes were permeablized by exposure to 0.2%
Triton X-100 in PBS for 5 min at RT, followed by PBS washing.
Cells were subsequently covered with blocking solution (1% BSA/
0.1% NaN3 in PBS) and incubated at 4uC overnight with anti-
mouse IFNcR antibody (Invitrogen). After PBS washing, cells were
incubated with secondary AlexaFluor 568 goat Ab to rabbit IgG
(Molecular Probes). To visualize ganglioside (GM1) localization,
cells were incubated with GM1-specific cholera toxin (CTx) B
subunit-FITC (CTx-FITC; Sigma-Aldrich), respectively. Follow-
ing serial ethanol dehydration steps, samples were mounted onto
glass slides with ProLong Antifade reagent (Molecular Probes).
Slides were stored at220uC until analysis by confocal microscopy.
Fluorescence images were acquired at 6126 magnification on a
Bio-Rad Radiance 2000 MP confocal microscope as previously
described [33]. For FITC detection, an excitation wavelength was
set to 488 nm and emission was collected with a 550LP dichroic
mirror and 515/28-nm BP filter. For Alexa 568 detection, an
excitation of 568 nm was used, and emission was collected using a
600 nm LP filter. Ten images, with a minimum of four cells per
image, were collected randomly per treatment group. Data are
representative of 3 independent experiments. For data analysis,
regions of interest were selected by drawing polygons around each
cell boundary. Colocalization of IFNc with the raft marker in each
cell was quantified as percentage of colocalized pixel area (both
green and red) over total raft pixel area (green) according to the
algorithm provided with the Meridian Ultima Work Station
(Meridian Instruments).
Statistical Analysis
Data were statistically evaluated with Excel or GraphPad
Prizm software, version 4.0. Comparisons between more than
two groups over time were assessed by ANOVA and Tukey-
Kramer test was performed when ANOVA results were
significant. Differences between treatments and control were
analyzed by using the Student’s t-test for samples with equal
variance, considering p values ,0.05 as significant. Data are
presented as means and error bars represent standard errors of
three independent experiments.
Supporting Information
Figure S1 Suppression of TNFa production and CD40 and
CD86 expression by DHA in infected J774A.1 cells after IFNc
treatment. Macrophages were incubated with 50uM DHA, AA or
PA for 24 h and infected with M. tuberculosis for 1 h. Culture
supernatants were quantified for TNFa or incubated with PE-
conjugated antibodies to CD40 and CD86 and fluorescence
intensity was quantified by FACS analysis, as described in the
Materials and Methods. a. Quantitative data represent the
concentration of TNFa post infection (pictograms per milliliter;
mean6SEM; n= 9).* Indicates a significant effect of DHA within
the same interval compared to Control, PA, or AA groups
** p,0.05. b. Quantitative data represent the relative percentage
of PE fluorescence (mean6SEM; n=9) for CD40 and CD86.
* Indicates a significant effect of DHA compared to Control, PA
and AA groups * p,0.01** p,0.05. Data are representative of
three independent experiments. Abbreviations used: PA, palmitic
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acid; AA, arachidonic acid; DHA, docosahexaenoic acid; PE,
phycoerythrin.
Found at: doi:10.1371/journal.pone.0010878.s001 (1.66 MB TIF)
Figure S2 DHA reduces mycobacterial killing and impairs
phagolysosmal fusion in IFNc-stimulated J774A.1 macrophages.
Cells were incubated with 50uM DHA, AA or PA for 24 h and
infected with 10 MOI GFP-expressing M. tuberculosis for 1 h. a.
The relative percentage of Mtb-infected cells was quantified by
flow cytometry, as described in the Materials and Methods.
Quantitative data represent the percentage of infected cells
(mean6SEM; n= 9). b. Phagolysosome maturation was defined
based on acquisition of lysotracker by GFP-Mtb-containing
phagosomes and visualized by fluorescent microscopy, as de-
scribed in the Materials and Methods. Percentages of Lysotracker-,
LAMP-1, LAMP3-, Rab5-, Rab7-positive mycobacterial phago-
somes. Data represent the percentage of colocalization (mean6
SEM; n= 5). ).* Indicates a significant effect of DHA within the
same interval compared to Control, PA, or AA groups * p,0.01,
** p,0.05, ***P,0.001. Data are representative of three
independent experiments. Abbreviations used: PA, palmitic acid;
AA, arachidonic acid; DHA, docosahexaenoic acid.
Found at: doi:10.1371/journal.pone.0010878.s002 (4.85 MB TIF)
Figure S3 DHA impairs oxidative metabolism in infected
J774A.1 cells activated with IFNc. Cells were incubated with
50uM DHA, AA or PA for 24 h and infected with 20 MOI Mtb.
Reactive oxygen intermediates were estimated by FACS, as
described in the Materials and Methods. Quantitative data show
the relative percentage of EB red fluorescence (mean6SEM;
n=9). * Indicates a significant effect of DHA compared to the
other three treatment groups, *p,0.01. Data are representative of
three independent experiments. Abbreviations used: PA, palmitic
acid; AA, arachidonic acid; DHA, docosahexaenoic acid.
Found at: doi:10.1371/journal.pone.0010878.s003 (0.48 MB TIF)
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